SCM
Soleus Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.3M | Sell |
658,145
-472,534
| -42% | -$8.85M | 0.82% | 34 |
|
|
2025
Q1 | $20.3M | Hold |
1,130,679
| – | – | 1.46% | 21 |
|
|
2024
Q4 | $19M | Buy |
1,130,679
+195,891
| +21% | +$3.29M | 1.2% | 24 |
|
|
2024
Q3 | $15.1M | Sell |
934,788
-108,909
| -10% | -$1.76M | 1.17% | 31 |
|
|
2024
Q2 | $8.58M | Sell |
1,043,697
-8,198,289
| -89% | -$67.4M | 0.76% | 43 |
|
|
2024
Q1 | $13.7M | Sell |
9,241,986
-200,593
| -2% | -$297K | 1.02% | 31 |
|
|
2023
Q4 | $13.7M | Sell |
9,442,579
-5,360,436
| -36% | -$7.77M | 1.52% | 21 |
|
|
2023
Q3 | $16M | Buy |
14,803,015
+625,000
| +4% | +$675K | 1.48% | 23 |
|
|
2023
Q2 | $18.3M | Buy |
14,178,015
+1,375,000
| +11% | +$1.77M | 2.03% | 14 |
|
|
2023
Q1 | $16.9M | Buy |
+12,803,015
| New | +$16.9M | 1.75% | 14 |
|